Literature DB >> 6951632

Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.

A S Glicksman, T F Pajak, A Gottlieb, N Nissen, L Stutzman, M R Cooper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951632

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  14 in total

1.  Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.

Authors:  S Devereux; T G Selassie; G Vaughan Hudson; B Vaughan Hudson; D C Linch
Journal:  BMJ       Date:  1990-11-10

Review 2.  Leukaemia and cancer chemotherapy.

Authors:  C J Williams
Journal:  BMJ       Date:  1990-07-14

3.  Case report 409: Non-Hodgkin lymphoma (diffuse histiocytic or malignant lymphoma, diffuse, large cell B-cell immunophenotype).

Authors:  T S Samuels; B A Howard; J D Rubenstein; J Srigley
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

4.  Therapy-related acute nonlymphocytic leukemia: clinical aspects.

Authors:  J Pedersen-Bjergaard
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 5.  The iatrogenic leukaemias induced by radio- and/or chemotherapy.

Authors:  Y Najean
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

Review 6.  Primary multifocal osseous Hodgkin disease: a case report and review of the literature.

Authors:  C Gebert; J Hardes; H Ahrens; H Buerger; W Winkelmann; G Gosheger
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-15       Impact factor: 4.553

Review 7.  Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B.

Authors:  Mark R Green; Stephen L George; Richard L Schilsky
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

8.  The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function.

Authors:  J A Radford; N G Testa; D Crowther
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

9.  Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.

Authors:  A J Swerdlow; J A Barber; A Horwich; D Cunningham; S Milan; R Z Omar
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Mutagenesis after cancer therapy.

Authors:  K T Kelsey; M Caggana; P M Mauch; C N Coleman; J R Clark; H L Liber
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.